| 1 |
Ghafouri-Fard S, Shoorei H, Hussen BM, Dong P, Zhai T, Taheri M, Samadian M. The significance of N6-methyladenosine-modified non-coding RNAs in different disorders. Eur J Pharmacol 2023;946:175644. [PMID: 36921707 DOI: 10.1016/j.ejphar.2023.175644] [Reference Citation Analysis]
|
| 2 |
Liu Z, Gao L, Cheng L, Lv G, Sun B, Wang G, Tang Q. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. Exp Mol Med 2023. [PMID: 36854773 DOI: 10.1038/s12276-023-00944-y] [Reference Citation Analysis]
|
| 3 |
Chen J, Guo B, Liu X, Zhang J, Zhang J, Fang Y, Zhu S, Wei B, Cao Y, Zhan L. Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting. Exp Hematol Oncol 2022;11:98. [DOI: 10.1186/s40164-022-00357-z] [Reference Citation Analysis]
|
| 4 |
Zhou S, Zhong Z, Lu Y, Li Y, Yao H, Zhao Y, Guo T, Yang K, Li Y, Chen S, Huang K, Lian G. A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. Cancers 2022;14:4722. [DOI: 10.3390/cancers14194722] [Reference Citation Analysis]
|
| 5 |
Ma X, Ren H, Zhang Y, Wang B, Ma H. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway. Environ Toxicol 2022. [PMID: 36125241 DOI: 10.1002/tox.23656] [Reference Citation Analysis]
|
| 6 |
Geng R, Chen T, Zhong Z, Ni S, Bai J, Liu J. The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer. Cancers (Basel) 2022;14:4056. [PMID: 36011053 DOI: 10.3390/cancers14164056] [Reference Citation Analysis]
|
| 7 |
Liu J, Zhao W, Zhang L, Wang X. The emerging roles of N6-methyladenosine (m6A)-modified long non-coding RNAs in human cancers. Cell Death Discov 2022;8:255. [PMID: 35534472 DOI: 10.1038/s41420-022-01050-0] [Reference Citation Analysis]
|
| 8 |
Huang W, Kong F, Li R, Chen X, Wang K. Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer. Front Oncol 2022;12:827956. [PMID: 35155260 DOI: 10.3389/fonc.2022.827956] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 9 |
Chen DH, Zhang JG, Wu CX, Li Q. Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets. Front Cell Dev Biol 2021;9:778582. [PMID: 35004679 DOI: 10.3389/fcell.2021.778582] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 10 |
Liu M, Zhang H, Li Y, Wang S. Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance. Cancer Biother Radiopharm 2022. [PMID: 35133881 DOI: 10.1089/cbr.2021.0339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Chang LL, Xu XQ, Liu XL, Guo QQ, Fan YN, He BX, Zhang WZ. Emerging role of m6A methylation modification in ovarian cancer. Cancer Cell Int 2021;21:663. [PMID: 34895230 DOI: 10.1186/s12935-021-02371-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Zhou Y, Li J, Yang X, Song Y, Li H. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (TOP2A). Bioengineered 2021;12:12003-22. [PMID: 34787052 DOI: 10.1080/21655979.2021.2002494] [Reference Citation Analysis]
|
| 13 |
Yan Y, Peng J, Liang Q, Ren X, Cai Y, Peng B, Chen X, Wang X, Yi Q, Xu Z. Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.10.004] [Reference Citation Analysis]
|
| 14 |
Garbincius JF, Elrod JW. Mitochondrial calcium exchange in physiology and disease. Physiol Rev 2021. [PMID: 34698550 DOI: 10.1152/physrev.00041.2020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 15 |
Ye M, Lin Y, Pan S, Wang ZW, Zhu X. Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis. Front Oncol 2021;11:745808. [PMID: 34631583 DOI: 10.3389/fonc.2021.745808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Xu Z, Jin H, Duan X, Liu H, Zhao X, Fan S, Wang Y, Yao T. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis. Environ Toxicol 2021;36:2562-77. [PMID: 34520102 DOI: 10.1002/tox.23370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 17 |
Liu B, Xiang W, Liu J, Tang J, Wang J, Liu B, Long Z, Wang L, Yin G, Liu J. The regulatory role of antisense lncRNAs in cancer. Cancer Cell Int 2021;21:459. [PMID: 34461912 DOI: 10.1186/s12935-021-02168-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 18 |
Liu Z, Han M, Meng N, Luo J, Fu R. lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma. Oxid Med Cell Longev 2021;2021:9969449. [PMID: 34422217 DOI: 10.1155/2021/9969449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Cao C, Li J, Li G, Hu G, Deng Z, Huang B, Yang J, Li J, Cao S. Long Non-coding RNA TMEM220-AS1 Suppressed Hepatocellular Carcinoma by Regulating the miR-484/MAGI1 Axis as a Competing Endogenous RNA. Front Cell Dev Biol 2021;9:681529. [PMID: 34422806 DOI: 10.3389/fcell.2021.681529] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Cui S, Li F. RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑6884‑5p thus releasing TOP2A mRNA. Oncol Rep 2021;46:221. [PMID: 34414458 DOI: 10.3892/or.2021.8172] [Reference Citation Analysis]
|
| 21 |
Dang Q, Shao B, Zhou Q, Chen C, Guo Y, Wang G, Liu J, Kan Q, Yuan W, Sun Z. RNA N 6-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications. Front Oncol 2021;11:681781. [PMID: 34211849 DOI: 10.3389/fonc.2021.681781] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Feng Y, Hu X, Ma K, Zhang B, Sun C. Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma. Biomed Res Int 2021;2021:6640652. [PMID: 34095306 DOI: 10.1155/2021/6640652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 23 |
Rong D, Sun G, Wu F, Cheng Y, Sun G, Jiang W, Li X, Zhong Y, Wu L, Zhang C, Tang W, Wang X. Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers. Mol Ther Nucleic Acids 2021;25:67-82. [PMID: 34188972 DOI: 10.1016/j.omtn.2021.04.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 24 |
Tan F, Zhao M, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Xiang B, Zhou M, Li X, Li Y, Li G, Zeng Z, Xiong W, Guo C. N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies. J Exp Clin Cancer Res 2021;40:146. [PMID: 33926508 DOI: 10.1186/s13046-021-01952-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 25 |
Cui S, Li C. RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA. Oncol Rep 2021;45:111. [PMID: 33907841 DOI: 10.3892/or.2021.8062] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 26 |
Sun Y, Zong C, Liu J, Zeng L, Li Q, Liu Z, Li Y, Zhu J, Li L, Zhang C, Zhang W. C-myc promotes miR-92a-2-5p transcription in rat ovarian granulosa cells after cadmium exposure. Toxicol Appl Pharmacol 2021;421:115536. [PMID: 33865896 DOI: 10.1016/j.taap.2021.115536] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 27 |
Seborova K, Vaclavikova R, Rob L, Soucek P, Vodicka P. Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer. Cancers (Basel) 2021;13:1839. [PMID: 33921525 DOI: 10.3390/cancers13081839] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 28 |
Lan Y, Liu B, Guo H. The role of M6A modification in the regulation of tumor-related lncRNAs. Mol Ther Nucleic Acids 2021;24:768-79. [PMID: 33996258 DOI: 10.1016/j.omtn.2021.04.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 29 |
Li C, Dong B, Xu X, Li Y, Wang Y, Li X. LncRNA ARAP1-AS1 aggravates the malignant phenotypes of ovarian cancer cells through sponging miR-4735-3p to enhance PLAGL2 expression. Cytotechnology 2021;73:363-72. [PMID: 34149172 DOI: 10.1007/s10616-021-00463-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Yao L, Yin H, Hong M, Wang Y, Yu T, Teng Y, Li T, Wu Q. RNA methylation in hematological malignancies and its interactions with other epigenetic modifications. Leukemia 2021;35:1243-57. [PMID: 33767371 DOI: 10.1038/s41375-021-01225-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 31 |
Natarajan GK, Mishra J, Camara AKS, Kwok WM. LETM1: A Single Entity With Diverse Impact on Mitochondrial Metabolism and Cellular Signaling. Front Physiol 2021;12:637852. [PMID: 33815143 DOI: 10.3389/fphys.2021.637852] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 32 |
Zhang X, Zhong L, Zou Z, Liang G, Tang Z, Li K, Tan S, Huang Y, Zhu X. Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases. Front Oncol 2021;11:623170. [PMID: 33816257 DOI: 10.3389/fonc.2021.623170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 33 |
Zhao Y, Chen Y, Jin M, Wang J. The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling. Theranostics 2021;11:4549-66. [PMID: 33754077 DOI: 10.7150/thno.54967] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 34 |
Liu W, Zhan J, Zhong R, Li R, Sheng X, Xu M, Lu Z, Zhang S. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway. Technol Cancer Res Treat 2021;20:1533033821990074. [PMID: 33641529 DOI: 10.1177/1533033821990074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 35 |
Zuo L, Su H, Zhang Q, Wu WY, Zeng Y, Li XM, Xiong J, Chen LF, Zhou Y. Comprehensive analysis of lncRNAs N6-methyladenosine modification in colorectal cancer. Aging (Albany NY) 2021;13:4182-98. [PMID: 33493136 DOI: 10.18632/aging.202383] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 36 |
Dai W, Zeng W, Lee D. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis. J Gene Med 2021;23:e3306. [PMID: 33450091 DOI: 10.1002/jgm.3306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 37 |
Wang Z, Zhang J, Liu Y, Zhao R, Zhou X, Wang H. An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach. Biomed Res Int 2020;2020:5717498. [PMID: 33381557 DOI: 10.1155/2020/5717498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 38 |
Braga EA, Fridman MV, Moscovtsev AA, Filippova EA, Dmitriev AA, Kushlinskii NE. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms. Int J Mol Sci 2020;21:E8855. [PMID: 33238475 DOI: 10.3390/ijms21228855] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 39 |
Nguyen VHL, Yue C, Du KY, Salem M, O'Brien J, Peng C. The Role of microRNAs in Epithelial Ovarian Cancer Metastasis. Int J Mol Sci 2020;21:E7093. [PMID: 32993038 DOI: 10.3390/ijms21197093] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 40 |
Xue L, Li J, Lin Y, Liu D, Yang Q, Jian J, Peng J. m6 A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer. J Cell Physiol 2021;236:2649-58. [PMID: 32892348 DOI: 10.1002/jcp.30023] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 41 |
Shen H, Lan Y, Zhao Y, Shi Y, Jin J, Xie W. The emerging roles of N6-methyladenosine RNA methylation in human cancers. Biomark Res 2020;8:24. [PMID: 32612834 DOI: 10.1186/s40364-020-00203-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 42 |
Liu J, Zhu Y, Ge C. LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924. Cancer Cell Int 2020;20:249. [PMID: 32550827 DOI: 10.1186/s12935-020-01322-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 43 |
Zhang W, Wang B, Wang Q, Zhang Z, Shen Z, Ye Y, Jiang K, Wang S. Lnc-HSD17B11-1:1 Functions as a Competing Endogenous RNA to Promote Colorectal Cancer Progression by Sponging miR-338-3p to Upregulate MACC1. Front Genet 2020;11:628. [PMID: 32595704 DOI: 10.3389/fgene.2020.00628] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 44 |
Liu S, Du Q, Rao Y, Liu C, Qu P. Long non-coding RNA NPBWR1-2 affects the development of ovarian cancer via multiple microRNAs. Oncol Lett 2020;20:685-92. [PMID: 32565993 DOI: 10.3892/ol.2020.11639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 45 |
Salamini-Montemurri M, Lamas-Maceiras M, Barreiro-Alonso A, Vizoso-Vázquez Á, Rodríguez-Belmonte E, Quindós-Varela M, Cerdán ME. The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use. Cancers (Basel) 2020;12:E1020. [PMID: 32326249 DOI: 10.3390/cancers12041020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
